Navigation Links
FDA Proposes Tougher Warnings for Tanning Beds
Date:5/7/2013

ially since the rise in skin cancer, especially in young people, has been documented. I hope that this legislation keeps more sunlamps off the shelves and away from consumers."

Dr. Jennifer Stein, assistant professor of dermatology at NYU Langone Medical Center in New York City, agreed, calling the reclassification of tanning beds "an important step in making the public aware of the dangers of tanning beds."

She said that "indoor tanning damages the skin and is associated with skin cancers, including melanoma -- a potentially fatal form of skin cancer. Fortunately many states have passed bans on tanning bed use in minors. We have seen an increase in skin cancers among young women who have used tanning beds."

The American Suntanning Association, a trade association of tanning salons, issued this statement Monday evening: "The professional sunbed community has not had any input in this preliminary proposal thus far. We remain dedicated to sunburn prevention and look forward to working with the FDA to improve consumer protection and to assure that all information regarding indoor tanning is in accordance with the science."

The FDA's reluctance to impose an outright ban on access to tanning beds for minors runs counter to a decision from an advisory panel the FDA commissioned to look at the issue in 2010. That ruling advocated barring minors from using tanning beds, or at least requiring parental consent.

In the same year, the American Academy of Pediatrics also came out in favor of a ban on tanning bed use by people under the age of 18. "Pediatricians should support and advocate for legislation to ban access to tanning parlors for children younger than 18 years," the AAP said in its policy statement.

The AAP also noted that other organizations, including the World Health Organization, the American Medical Association and the American Academy of Dermatology, already support such a ban.

Speaking at the time of the AAP recommen
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. IADR/AADR publish studies on severe early childhood caries - proposes new classification
2. EPA Proposes New Cuts on Levels of Soot in Air
3. FDA Proposes New Rules to Strengthen Food Safety
4. FDA Proposes Tighter Regulation of Public Defibrillators
5. EPA Proposes Cleaner Fuel, Car Standards
6. Stress May Be Tougher on Womens Hearts Than Mens: Study
7. Cardiovascular disease community calls for tougher targets to curb global risk
8. FDA Panel Weighs Tougher Restrictions on Some Prescription Painkillers
9. FDA Panel Votes for Tougher Curbs on Vicodin, Other Painkillers
10. Poll Finds Broad Support for Tougher Gun Laws
11. Million March Against Child Abuse: Walks to Raise Awareness and Ask for Tougher Sentencing for Violent Crimes Against Children in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Proposes Tougher Warnings for Tanning Beds
(Date:7/29/2014)... have discovered a chemical alteration in a single human ... larger studies, could give doctors a simple blood test ... , The discovery, described online in The American ... gene involved in the function of the brain,s response ... what might otherwise be an unremarkable reaction to the ...
(Date:7/29/2014)... Denver, Colorado (PRWEB) July 29, 2014 Daily ... the author of this program claims that he cured his ... the author decided to share part of his experience. ... nasal polys permanently and naturally in just 4 days. Since ... share it with sufferers from all around the world. ...
(Date:7/29/2014)... Daily Gossip reveals in its Leaky Gut Cure ... and functional medicine practitioner, who spent years looking for a ... suffered from leaky gut, too, so this is what determined ... treatment. , Karen Brimeyer decided to share her story, ... the world. The author of the Leaky Gut Cure program ...
(Date:7/29/2014)... New York (PRWEB) July 29, 2014 ... protecting the rights of victims injured by defective drugs ... has been filed by plaintiffs in Canada who allege ... of cardiovascular events with the low testosterone injection ... on July 22, 2014 in the Ontario Superior Court ...
(Date:7/29/2014)... 29, 2014 Daily Gossip reveals in its ... holistic system that will permanently eliminate all the symptoms associated ... natural treatment will banish symptoms such as mild hearing loss, ... heard by patients will be gone forever. , The method ... The author of this program says that at the end ...
Breaking Medicine News(10 mins):Health News:A blood test for suicide? 2Health News:A blood test for suicide? 3Health News:Nasal Polyps Treatment Miracle Review Reveals How to Cure Nasal Polyps Without Surgery 2Health News:Leaky Gut Cure Review Reveals Karen Brimeyer’s Natural Way to Heal Leaky Gut 2Health News:Class Action Lawsuit in Canada Alleges Manufacturer of Delatestryl Testosterone Injection Failed to Warn of Cardiovascular Risks, Parker Waichman LLP Reports 2Health News:Class Action Lawsuit in Canada Alleges Manufacturer of Delatestryl Testosterone Injection Failed to Warn of Cardiovascular Risks, Parker Waichman LLP Reports 3Health News:Tinnitus Miracle Review Exposes the Only Holistic System for Tinnitus Cure 2
... , ARLINGTON, Va., July 23 During ... Majority Leader Tom Daschle and Blue Dog Democrat Rep. Jason ... in the reform of the U.S. healthcare system. The ... medical equipment and services. The American Association for Homecare hosted ...
... , , , ... ), a leading provider of optical components, modules and subsystems, today announced ... June 27, 2009. Oclaro, Inc. was formed April 27, 2009 from ... Avanex Corporation. , , "Being positive Adjusted ...
... Calif., July 23 Oscar Wright, chief executive officer of United Advocates ... Donuts shop, participated in an interview and debate Wednesday on KTVU,s ... , Oscar Wright released this statement today: , ... the U.S. Small Business Administration, I appreciate an individual,s goal to live ...
... might be slowing down among poor families , THURSDAY, ... low-income families in the United States are considered obese, a ... that the news is not all bad: The childhood obesity ... this group. , Among 2- to 4-year-olds from low-income families, ...
... , , PITTSBURGH, July 23 ... stopping in Pennsylvania throughout the week of July 27-31 at ... access information on programs that provide prescription medicines for free ... 8.2 percent -- compared to 5.1% a year ago -- ...
... a cancer-killing protein, scientists at the University of Kentucky,s Markey ... UK professor of radiation medicine, have determined that the tumor-suppressor ... expressing the Par-4 gene, is in fact secreted by most ... cancer cells by binding to receptors on the cell surface. ...
Cached Medicine News:Health News:Sen. Tom Daschle, Rep. Jason Altmire, Healthcare Experts Tout Homecare as Cost-Effective Solution in the Healthcare Reform Process 2Health News:Sen. Tom Daschle, Rep. Jason Altmire, Healthcare Experts Tout Homecare as Cost-Effective Solution in the Healthcare Reform Process 3Health News:Oclaro Reports Positive Adjusted EBITDA in First Post-Merger Quarter 2Health News:Oclaro Reports Positive Adjusted EBITDA in First Post-Merger Quarter 3Health News:Oclaro Reports Positive Adjusted EBITDA in First Post-Merger Quarter 4Health News:Oclaro Reports Positive Adjusted EBITDA in First Post-Merger Quarter 5Health News:Oclaro Reports Positive Adjusted EBITDA in First Post-Merger Quarter 6Health News:Oclaro Reports Positive Adjusted EBITDA in First Post-Merger Quarter 7Health News:Oclaro Reports Positive Adjusted EBITDA in First Post-Merger Quarter 8Health News:Oclaro Reports Positive Adjusted EBITDA in First Post-Merger Quarter 9Health News:Oclaro Reports Positive Adjusted EBITDA in First Post-Merger Quarter 10Health News:Oclaro Reports Positive Adjusted EBITDA in First Post-Merger Quarter 11Health News:Oclaro Reports Positive Adjusted EBITDA in First Post-Merger Quarter 12Health News:Oclaro Reports Positive Adjusted EBITDA in First Post-Merger Quarter 13Health News:Oclaro Reports Positive Adjusted EBITDA in First Post-Merger Quarter 14Health News:Oclaro Reports Positive Adjusted EBITDA in First Post-Merger Quarter 15Health News:Oclaro Reports Positive Adjusted EBITDA in First Post-Merger Quarter 16Health News:Oclaro Reports Positive Adjusted EBITDA in First Post-Merger Quarter 17Health News:Oclaro Reports Positive Adjusted EBITDA in First Post-Merger Quarter 18Health News:Oclaro Reports Positive Adjusted EBITDA in First Post-Merger Quarter 19Health News:Mental Health Advocates Call for Psycho Donuts to Do the Right Thing 2Health News:1 in 7 Low-Income Preschoolers Is Obese 2Health News:Partnership for Prescription Assistance Prepared to Help Pennsylvania Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help Pennsylvania Workers Hurt by Recession 3Health News:Partnership for Prescription Assistance Prepared to Help Pennsylvania Workers Hurt by Recession 4Health News:Human cells secrete cancer-killing protein, UK study finds 2
(Date:7/29/2014)... 2014  Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ... healthcare conferences during the third quarter, the 2014 Avondale ... Healthcare 2014 Conference.  Alexza,s corporate presentation will be webcast ... each event are below: , 2014 Avondale ... Boston , MA.  The format is ...
(Date:7/29/2014)... ROCKVILLE, Md. , July 29, 2014  Synthetic ... anti-infective biologic and drug candidates targeting specific pathogens that ... view of the unusual market activity in the Company,s ... Company in accordance with its usual practice. The Company ... unusual market activity. About Synthetic Biologics, Inc. ...
(Date:7/29/2014)... 2014 Numotion,s Board of Directors has announced that ... be the company,s new Chief Executive Officer. ... GE where he worked primarily for GE Healthcare Services, running ... $5 billion. His most recent position was as President and ... am thrilled to join Numotion," said Mike Swinford . ...
Breaking Medicine Technology:Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 2Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 3Synthetic Biologics, Inc. States that Its Policy is Not to Comment on Unusual Market Activity 2Numotion Names Mike Swinford CEO 2
... Seen Since Presentation at ASCO ... Alvespimycin Plus Trastuzumab Plus ... Paclitaxel Regimen, HAYWARD, Calif., Sept. ... a Phase 1 clinical,trial showing that alvespimycin, its second-generation Hsp90 inhibitor,demonstrated antitumor ...
... Sept. 7 Roche announced today that three,clinical data ... for presentation at the 2007 Breast Cancer Symposium in ... abstracts include data from the XeNA (Xeloda in NeoAdjuvant),trial, ... Herceptin in,patients with invasive breast cancer. The third presentation ...
Cached Medicine Technology:Kosan's Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial 2Kosan's Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial 3Kosan's Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial 4Kosan's Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial 5Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium 2Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium 3
... there is a more efficient way ... fully portable battery operated patient warming ... surgical teams with a compact and ... the entire surgical process. Its unique ...
... patient warming system consists of our ... range of blankets for use with ... clinical applications. Blankets are available for ... and paediatric sizes and a sterile ...
MAMMOMAT 3000 Nova supports high-volume screening as well as interventional diagnostics. Versatile procedural capabilities include magnification, stereotactic biopsy, needle localization, and specime...
The Synoptiscope(L-2510B) has a wide variety of functions including binocular function diagnosis and treatment....
Medicine Products: